Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
The Journal of Invasive Cardiology|January 1, 2021
Predicting Significant Iliac Vein Compression Using a Probability Scoring System Derived From Minimal Luminal Area on Computed Tomography Angiography in Patients 65 Years of Age or YoungerNicolas W Shammas, Sue Jones-Miller, Torin Kovach, et al.
Biochemistry|February 15, 2007
Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptideDavid P Smith, Giuseppe D Ciccotosto, Deborah J Tew, et al.
Implementation Science : IS|June 3, 2014
Clinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocolBernadette Bea Brown, Jane Young, David P Smith, et al.
Scientific Reports|March 11, 2018
Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up StudyVisalini Nair-Shalliker, Albert Bang, Marianne Weber, et al.
BMJ (Clinical Research Ed.)|December 1, 2009
Quality of life three years after diagnosis of localised prostate cancer: population based cohort studyDavid P Smith, Madeleine T King, Sam Egger, et al.
Patient Education and Counseling|January 25, 2025
Are AI chatbots concordant with evidence-based cancer screening recommendations?Brooke Nickel, Julie Ayre, M Luke Marinovich, et al.
The Medical Journal of Australia|April 5, 2012
Prostate-specific antigen levels in men aged 70 years and over: findings from the CHAMP studyMelisa J Litchfield, Robert G Cumming, David P Smith, et al.
BMC Cancer|February 28, 2013
A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancerSuzanne K Chambers, David P Smith, Martin Berry, et al.
World Journal of Urology|November 6, 2013
The relationship between solar UV exposure, serum vitamin D levels and serum prostate-specific antigen levels, in men from New South Wales, Australia: the CHAMP studyVisalini Nair-Shalliker, David P Smith, Mark Clements, et al.
Plos One|February 14, 2015
The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisationSu Ling Leong, Mark G Hinds, Andrea R Connor, et al.
Pageof 22